Disease Markers

Biomarkers and Pathophysiological Mechanisms Involved in Stress-related Chronic Diseases

Publishing date
01 May 2018
Submission deadline
05 Jan 2018

1Federal University of Fronteira Sul, Chapecó, Brazil

2The University of Texas Health Science Center at Houston, Houston, USA

Biomarkers and Pathophysiological Mechanisms Involved in Stress-related Chronic Diseases


Stress is currently recognized as a major risk factor for several chronic diseases and may account for more than 75% of all visits to primary care physicians. Thus, the investigation of biomarkers and mechanisms involved in the pathophysiology of stress-related chronic conditions is of great relevance to the effort of preventing and reducing disease burden, as well as treating and monitoring disease evolution.

We invite researchers to submit high quality manuscripts reporting original research results and review articles related to the scientific advances in the area of stress-related chronic diseases. We encourage submissions covering the role of biomarkers on aspects such as risk estimation, susceptibility factors, diagnosis, disease staging, prognosis, prediction of treatment response/resistance, and mechanisms of disease pathophysiology. This issue will provide our readers with a better understanding of the importance of biomarkers in stress-related chronic diseases and will unveil the recent advancements in this area.

Potential topics include but are not limited to the following:

  • Anxiety, depression, and other neuropsychiatric disorders
  • Neurodegenerative disorders
  • Hypertension and other cardiovascular diseases
  • Diabetes and metabolic syndrome
  • Cancer
  • Peptic ulcer and alcohol abuse-induced cirrhosis
Disease Markers
 Journal metrics
See full report
Acceptance rate10%
Submission to final decision84 days
Acceptance to publication22 days
Journal Citation Indicator-
Impact Factor-

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.